Arcadia Biosciences, Inc. (RKDA) Q1 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by. My name is Prilla and I will be your conference operator today. At this time, I would like to welcome everyone to the Arcadia Biosciences Q1 2024 Financial Results and Business Highlights Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press the star followed by the number one on your telephone keypad. If you would like to withdraw your question, please press the star one again. Thank you. I would now like to turn the conference over to TJ Schaefer, Chief Financial Officer at Arcadia. Please go ahead. Thank you, and good afternoon. Joining me on the call today is Dan Jaycott, Arcadia's President and Chief Executive Officer. This call is being webcast, and you can refer to the company's press release at arcadiabio.com. Before we start, we would like to remind you that Arcadia Biosciences will be making forward-looking statements on this call based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company's actual performance and results may differ materially from those described or implied today. You can review the company's Safe Harbor language in our most recently filed 10-K. With that, I'll now turn the call over to Stan. Good afternoon, everyone, and thank you for joining us today to review our first quarter results for 2024. Since we last talked six weeks ago, I am pleased to report that the positive business trends from Q4 2023 have continued in Q1 2024. Revenue continues to grow, both sequentially and year over year. Our gross profit margins have been greater th...